TripSitter Clinic Ltd.
TripSitter Clinic Ltd., through its wholly-owned subsidiary TripSitter Clinic Corp, is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The Company’s consultative virtual clinic, TripSitter.Clinic, is a SaaS platform that provides care, monitoring and coaching while connecting patients with licensed physicians in the United States who can evaluate for a prescribed psychedelic treatment program of therapeutic low-dose ketamine medication. TripSitter is not a primary care physician (PCP). TripSitter.Clinic requires prospective patients to provide a diagnosis from their PCP along with other health information to their chosen TripSitter physician during the initial intake process. When a patient is approved for treatment by their physician, TripSitter.Clinic connects the patient with experts who also use the platform to consult and coordinate with the patient and their physician.
TripSitter Clinic Ltd. (KETA)
Communiqués de presse
Le 26 novembre/November 2021
The common shares of TripSitter Clinic Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
TripSitter is a consultative virtual clinic and tele-health platform that connects prospective patients to a licensed physician in the United States who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication.